Category: Stock Market

Now could be a great time to buy some S&P/ASX 200 Index (ASX: XJO) materials and industrials shares, if brokers are to be believed.

Analysts have recently taken a fresh look at these companies, coming away with a more positive opinion on their stocks. In fact, one has been tipped to soar 18%.

Let’s take a look at four ASX 200 shares that have been upgraded by brokers this week.

4 ASX 200 shares upgraded by brokers this week

Core Lithium Ltd (ASX: CXO)

First off the bat is ASX 200 battery materials favourite Core Lithium.

This year has been transformative for the company. It saw its maiden lithium shipment sail in January and kicked off spodumene production in February. Such happenings may have turned sentiment in the company’s favour.

Indeed, broker JPMorgan appears more bullish on the stock than it previously was. It upped its outlook for the ASX 200 lithium share to neutral this week, The Australian reports.

ALS Ltd (ASX: ALQ)

Meanwhile, Goldman Sachs has initiated coverage of testing, inspection, certification, and verification services provider ALS.

The broker expects the company to benefit from the ongoing green metals trend, rating it a buy and tipping it to gain 16.2% to reach $12.56.

Seven Group Holdings Ltd (ASX: SVW)

Goldman Sachs has also slapped a buy rating and a $27.90 price target on industrials share Seven Group – representing a potential 17.8% upside.

The investment group holds major stakes in Boral Limited (ASX: BLD), Beach Energy Ltd (ASX: BPT), and Seven West Media Ltd (ASX: SWM).

Iluka Resources Limited (ASX: ILU)

Finally, critical minerals and rare earths minerals developer and producer Iluka Resources has also been the subject of a broker upgrade.

Barrenjoey upped its expectations for the ASX 200 share, The Australian reports. It’s been tipped to gain 9% to trade at $12.

The post 4 ASX 200 shares just upgraded by brokers, one with 18% upside appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Could this further cloud the outlook for ASX 200 lithium shares?
• Leading brokers name 3 ASX shares to buy today
• What on earth happened to the Core Lithium share price in March?
• These are the 10 most shorted ASX shares this week
• 5 things to watch on the ASX 200 on Monday

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/2cnxeBp

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has given back its morning gains and slipped into the red. At the time of writing, the benchmark index is down slightly to 7,221.3 points.

Four ASX shares that are falling more than most today are listed below. Here’s why they are dropping:

Energy Resources Of Australia Ltd (ASX: ERA)

The Energy Resources share price is down 10% to 18.5 cents. Investors have been selling this uranium developer’s shares after it announced a $369 million 5 for 1 entitlement offer. The company is aiming to raise the funds at a whopping 90.2% discount of 2 cents per share. The funds will be used partly to support its Ranger Project Area rehabilitation expenditure over the next 12 months.

Paradigm Biopharmaceuticals Ltd (ASX: PAR)

The Paradigm share price is down 6% to $1.35. This morning, this biopharmaceutical company released an update on a phase 2 clinical study of injectable pentosan polysulfate sodium (iPPS). Day 168 data from Paradigm’s trial demonstrates multiple signals that iPPS may slow disease progression in knee osteoarthritis. Some investors may have been looking for stronger data from the trial.

Piedmont Lithium Inc (ASX: PLL)

The Piedmont Lithium share price is down 5.5% to 84 cents. This follows a similarly sharp decline for this lithium miner’s NASDAQ listed shares during overnight trade on Wall Street. This appears to have been driven by broad weakness in the lithium industry.

Seek Ltd (ASX: SEK)

The Seek share price is down 2.5% to $23.62. Investors have been selling this job listings company’s shares after it revealed it would fall short of its revenue guidance in FY 2023 due to continued moderation of job ad volumes. Positively, management expects to still achieve its earnings guidance despite this. It also provided long term revenue guidance ahead of consensus expectations.

The post Why Energy Resources, Paradigm, Piedmont Lithum, and Seek shares are dropping today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Seek share price sinks 7% on guidance update
• Morgans names the best ASX shares to buy in April
• Why Block, Novonix, Piedmont Lithium, and Syrah shares are racing higher
• Why is the Sayona Mining share price having such a stellar end to the week?
• Piedmont Lithium share price surges 6% on ‘exciting milestone’

Motley Fool contributor James Mickleboro has positions in Seek. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Seek. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/91Ceg7y

CSL Limited (ASX: CSL) has fallen slightly on the stock market in the last month, but could now be the time to pounce?

CSL shares have descended 0.84% since market close on 4 April and are fetching $290.81 a piece at last look. In today’s trade, CSL shares are 0.03% in the red. For perspective, the S&P/ASX 200 Index (ASX: XJO) is rising 0.01% today.

Let’s take a look at the outlook for CSL stock going forward.

What’s ahead?

CSL is a global biotechnology company that operates a huge plasma collection network along with developing a range of life-saving therapies and vaccines.

CSL is one of multiple “recession-proof” shares according to Airlie Funds Management head of Australian equities Matt Williams.

Williams noted CSL’s collection costs are falling and could go down even more. In quotes provided to The Australian, Williams said:

During Covid, the cost of collecting plasma went up significantly. Those costs are
now reducing and in fact, a recession should actually lead to lower collection costs
because they won‘t have to pay their blood donors as much.

CSL is absolutely in that basket of recession-proof stocks. It‘s trading on a similar
multiple to Woolworths but it’s actually the cheapest multiple I’ve seen it for a long
time.

CSL reported a net profit of US$1.62 billion in the first half of the 2023 financial year. The company noted plasma collections were at record levels.

Meanwhile, the team at Morgans has also recently placed an add rating on CSL shares with a $337.92 price target. This implies an upside of about 16% based on CSL’s current share price.

Analysts are optimistic plasma collections will lift and more people will take the flu vaccine. Morgans said:

A key portfolio holding and key sector pick, we believe CSL is poised to break-out this year, a COVID exit trade, offering double-digit recovery in earnings growth as plasma collections increase, new products get approved and influenza vaccine uptake increases around ongoing concerns about respiratory viruses, with shares offering good value trading around its long-term forward multiple of ~30x.

CSL share price snapshot

The CSL share price has lifted nearly 9% in the last year.

CSL has a market capitalisation of about $140 billion based on the current share price.

The post Top broker says buy CSL stock while trading on ‘cheapest multiple in a long time’ appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Passive income: How much to invest to get $800 per month
• Morgans names the best ASX shares to buy in April
• This ASX share’s halved in 5 years, but I’m still sticking with it
• This ASX 200 giant is about to wake up from a 3-year slumber. Are you ready?
• Fundie loves these 2 ASX 200 shares that are ‘difficult to replicate’

Motley Fool contributor Monica O’Shea has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/VDHbnKo

The All Ordinaries Index (ASX: XAO) is in the red today – just. The benchmark is down 0.07% right now at 7,411.3. And that performance is being smashed by four ASX All Ords shares, each with big news.

Let’s take a closer look at the updates driving these stocks to market-beating heights on Tuesday.

4 ASX All Ords shares soaring on exciting updates

First up is Race Oncology Ltd (ASX: RAC). The All Ords biotech share is surging 5.18% to trade at $1.93 after the company released market research conducted by a third party.

Life science strategy firm Triangle Insights found Zantrene, the company’s cardio-protective and anti-cancer agent, could boast a market opportunity of up to US$5 billion. The company’s chair Dr John Cullity commented on the report, saying:

The findings have been entirely useful, informing potential treatment scenarios for Zantrene in breast cancer, an area in which we have promising historical data.

Joining the Race Oncology share price in the green is that of Aeris Resources Ltd (ASX: AIS).

The All Ords copper-gold producer announced a maiden mineral resource estimate (MRE) for its Kurrajong deposit this morning. The news has sent its shares 6.6% higher to trade at 70 cents at the time of writing.

The deposit, located within the Tritton tenement package, has an MRE of 2.2 million tonnes at 1.7% copper, including a high-grade massive sulphide lens of 1.1 million tonnes at 2.5% copper.

Another All Ords share posting a whopping gain on Tuesday is Queensland Pacific Metals Ltd (ASX: QPM).

The stock is up 23.8% right now, trading at 13 cents, on news of a collaboration agreement with a group of German companies.

The group has agreed to help advance and supply capital equipment to the All Ords company’s Townsville Energy Chemicals Hub (TECH) project.

Additionally, the ASX company has received a receipt of financing support from two German financial institutions. They’ve confirmed their interest in lending a combined $857 million.

Finally, shares in All Ords gold explorer Predictive Discovery Ltd (ASX: PDI) are soaring today. They’re up 6.25%, trading at 17 cents, on assay results from the company’s Bankan Gold Project.

Managing director Andrew Pardey commented on the findings, saying:

[The company] is working diligently towards completion of a scoping study by the end of 2023 to facilitate permitting in the first half of 2024.

Infill drilling to support further mineral resource upgrades in Q3 2023 is a crucial part of our strategy and will enable [Predictive Discovery] to deliver a robust scoping study based on a significant proportion of indicated mineral resources.

The post 4 ASX All Ords shares smashing the market on big news appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 5 ASX All Ords shares trading ex-dividend this week
• I believe these 2 beaten-up ASX shares are too cheap to ignore in April
• Guess which ASX All Ordinaries stock just crashed 25%
• Leading brokers name 3 ASX shares to buy today
• Why Aeris, Block, Fineos, and Tyro shares are racing higher

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/iZkhF5t

After a shaky start this morning, the All Ordinaries Index (ASX: XKO) is pushing higher at this point of Tuesday’s trading. At the time of writing, the All Ords has gained a tentative 0.07%, lifting the Index back over 7,420 points. But let’s talk about some ASX All Ords shares that might have a rough week in terms of share price.

When a company trades ex-dividend for an upcoming shareholder payment, we normally see a dip in said company’s share price. That’s because when a company goes ex-dividend, new investors are ineligible to receive the upcoming dividend in question. As such, the shares become notionally less valuable.

So let’s discuss five ASX All Ords shares that will experience this phenomenon this week.

5 ASX All Ords shares going ex-dividend this week

Ridley Corporation Ltd (ASX: RIC)

All Ords agricultural share Ridley Corporation is first up for discussion. This company declared an interim dividend of 4 cents per share, fully franked, back in February. Investors will see this payment arrive in their bank accounts on 24 April later this month. But eligibility for new investors will be shut off when Ridley shares trade ex-dividend tomorrow, 5 April.

Clover Corporation Limited (ASX: CLV)

All Ords nutritional ingredients company Clover Corporation is next up for examination. Clover also has an upcoming dividend in store for investors. The 2023 interim dividend of 0.75 cents per share, fully franked, is coming investors’ way on 27 April this month.

But again, investors will need to be quick if they wish to secure it. That’s because Clover’s ex-dividend date is also set for tomorrow, 5 April.

Imdex Limited (ASX: IMD)

Imdex is another All Ords share that will go ‘ex-div’ this week. In this mining services company’s case, investors can expect to see Imdex’s upcoming interim dividend arrive on 20 April. It will be a payment worth 1.5 cents per share, fully franked. But Imdex is another ASX All Ords share that will trade ex-dividend tomorrow, so time is running out for this one as well.

ARB Corporation Ltd (ASX: ARB)

All Ords provider of off-road equipment and accessories, ARB Corp, is our next share worth checking out. ARB declared an interim dividend of 32 cents per share, fully franked, back in February. Investors will bag this dividend payment later this month on 21 April. But once more, tomorrow is the ex-dividend day for ARB.

Brickworks Limited (ASX: BKW)

All Ords stalwart and construction materials company Brickworks is our final cab off the rank this Tuesday. Last month, Brickworks delighted investors with its announcement that this year’s interim dividend would be the highest the company has ever paid out at 23 cents per share, fully franked.

Unlike the other shares we’ve discussed today, Brickworks’ ex-dividend date for this payment has been set for 6 April (this Thursday). Payment will then arrive in investors’ mailboxes on 2 May next month.

The post 5 ASX All Ords shares trading ex-dividend this week appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 4 ASX All Ords shares smashing the market on big news
• Top ASX shares to buy in April 2023
• Guess which ASX All Ordinaries stock just crashed 25%
• Brokers name 3 ASX shares to buy now
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ARB Corporation, Brickworks, Clover, and Imdex. The Motley Fool Australia has positions in and has recommended Brickworks and Imdex. The Motley Fool Australia has recommended ARB Corporation. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/W1w4VGc

The Lynas Rare Earths Ltd (ASX: LYC) share price has taken a real beating in 2023.

Since the start of the year, the rare earths producer’s shares have fallen almost 17%.

However, that doesn’t take into account the very strong start to the year that its shares had.

The Lynas share price was up as much as 24% year to date at the end of January. So, from the top, the company’s shares have lost almost a third of their value.

This has been driven largely by comments out of Tesla, which revealed that the electric vehicle giant is planning to stop using rare earths in its vehicles.

In addition, news relating to its Malaysian licence weighed on its shares. That news reveals that its licence has been renewed but will now prohibit the import and processing of lanthanide concentrate after 1 July 2023.

These processes will have to be undertaken at Lynas’ Kalgoorlie Rare Processing Facility once operational.

Is the Lynas share price good value under $7?

Analysts at Bell Potter believe that the recent weakness in the Lynas share price has created a buying opportunity.

So much so, the broker has just upgraded its shares to a buy rating with a trimmed price target of $8.06. This implies potential upside of 23% for investors from current levels.

The broker believes there’s plenty of growth opportunities for the company outside Tesla. It commented:

We argue yes, despite near-term earnings risk perpetuated by the commissioning of Kalgoorlie (and replacement of Malaysia), a weaker near-term NdPr price (on the back of increased Chinese production quotas) and Teslas move to replace rare earth permanent magnets, we believe the recent ~34% sell-off to be largely overdone.

[W]e adjust our production and revenue outlook on a constrained ramp up at Kalgoorlie and lower near-term NdPr prices and adjust for the issue of new securities. Whilst the near-term risks are undeniable, we fundamentally believe LYC to be the sector leader in the Rare-earth space, with a sound balance sheet, multiple long-term growth pathways underpinned by arguably the best rare-earth deposit at Mt Weld.

The post Should I buy Lynas shares while they’re under $7? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Leading brokers name 3 ASX shares to buy today
• Why is the Lynas share price down 25% in a month?
• The Lynas share price has clocked five 52-week lows this month. Broker tips 25% upside
• ‘Top quality’: Expert picks 2 ASX 200 shares to buy at a nice discount
• Lynas share price resets 52-week low twice in one week

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/uJWyUsV

The S&P/ASX 200 Index (ASX: XJO) is climbing 0.07% today, but this ASX lithium stock is absolutely exploding.

The Li-S Energy Ltd (ASX: LIS) share price soared 62.7% from 25.5 cents to 41.5 cents this morning before retreating. The company’s share price is now rising 35% and trading at 34.5 cents.

So why is this ASX lithium stock charging higher today?

What’s going on?

Li-S Energy is developing lithium sulfur and lithium metal batteries for use in electric vehicles (EV).

Today, Li-S Energy advised it has developed new 20-layer battery cells using third generation semi-solid state lithium sulfur technology.

The new battery cells have 45% more volumetric energy density due to lower porosity cathode material.

Li-S Energy is using a low-flammability electrolyte to make the 20-layer cells, making them safer.

Commenting on the news, Li-S Energy CEO Lee Finniear said:

The development of these new battery cells is another validation of the strength of our
scientific and technical teams, and our collaboration with Deakin University and other
Australian and international institutions.

This outcome demonstrates the strength of our progress over the last year. In the coming months we look forward to commencing the production of commercial samples for our partners.

Li-S Energy share price snapshot

The Li-S Energy share price has fallen 58% in the last year. In the year to date, the company’s share price has risen 8%.

For perspective, the ASX 200 has fallen 3.8% in the past year and climbed 2.7% in the year to date.

This ASX lithium stock has a market capitalisation of about $57 million based on the current share price.

The post Guess which ASX lithium stock just rocketed 60% appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why was the Pilbara Minerals share price sold off in March?
• Investing $10k in Westpac shares could generate substantial passive income
• ANZ share price higher amid Suncorp Bank takeover news
• Seek share price sinks 7% on guidance update
• Could buying Westpac shares at under $22 make me rich?

Motley Fool contributor Monica O’Shea has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/hRSHMXD

The Pilbara Minerals Ltd (ASX: PLS) share price had an eventful month in March.

During the period, the lithium giant’s shares lost 5.5% of their value.

However, with just a few days remaining in the month, things were looking far worse for shareholders.

On 27 March, the Pilbara Minerals share price was down as low as $3.43. At that point, it was on course to record a monthly decline of 18%.

However, news that rival Liontown Resources Ltd (ASX: LTR) was a takeover target led to the whole lithium industry rebounding on 28 March. This saw Pilbara Minerals’ shares recover to finish the month at $3.94.

What happened last month?

The main drag on the Pilbara Minerals share price last month was falling spot lithium prices.

This sparked fears that the lower prices could mean that the lithium miner’s future earnings may not be as strong as some were forecasting.

However, it is worth noting that the company made an announcement of its own at the end of last month that could support its future earnings.

Pilbara Minerals announced that its board has approved its production expansion plans. This will ultimately see the company’s spodumene production capacity increase by a third to 1 million dry metric tonnes per annum in the coming years.

Is the Pilbara Minerals share price good value?

The team at Citi is positive on the Pilbara Minerals share price at the current level.

The broker currently has a buy rating and $4.60 price target on its shares, which implies potential upside of 20% for investors.

Citi is forecasting earnings per share of 80 cents in FY 2023, 68 cents in FY 2024, and then 73 cents in FY 2025. This is expected to underpin fully franked dividend yields of 6.3%, 4.5%, and then 5.3%, respectively.

The post Why was the Pilbara Minerals share price sold off in March? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Here are the 3 most heavily traded ASX 200 shares on Monday
• Could this further cloud the outlook for ASX 200 lithium shares?
• Why Austal, Netwealth, Perseus, and Pilbara Minerals shares are dropping
• These ASX 200 lithium shares could be takeover targets: Morgans
• Here are the 3 most heavily traded ASX 200 shares on Friday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/iH8ZmtY

Investing in S&P/ASX 200 Index (ASX: XJO) dividend shares can be a simple way of creating a passive income stream. Take Westpac Banking Corp (ASX: WBC) shares as an example.

Here’s how much a $10,000 investment in the ASX 200 big four bank stock could bring in in dividends.

Passive income

The Westpac share price last closed at $21.89. At that price, a $10,000 investment would see an investor walk away with 456 stocks and around $20 change (perhaps enough to cover brokerage fees).

Looking ahead, each Westpac share could bring in $1.53 of dividend income in financial year 2023, according to Morgans analysts.

Multiply $1.53 by 456 shares and you get $697.68. That may be how much passive income a $10,000 investment in Westpac shares could generate in the near term.

Could Westpac shares also provide capital gains?

And dividends may not be the only benefit an investor might receive from Westpac shares. The bank’s stock could provide capital gains as well.

It hit a 52-week high of $24.67 in April 2022. If it could rebound to such levels, a $10,000 investment today could be worth $12,617.52 in the future.

But brokers Morgans and Goldman Sachs are hopeful it could surpass that.

They have respective price targets of $25.80 and $27.74 on the stock – marking a potential upside of between 18% and 27%.

Though, there’s no guarantee the stock will provide gains in the future.

Particularly given investor sentiment towards the banking sector may have been dinted by a series of collapses among international banks last month.

What risks might face Westpac shares?

Of course, rocky investor sentiment brings about certain risks.

Though, Goldman Sachs ran its ruler over the Aussie banking sphere last month, giving it the thumbs up, as my Fool colleague James reports.

Beyond that, successive interest rate hikes from the Reserve Bank of Australia (RBA) have bolstered the bank’s net interest income. That could change in the coming years, potentially dragging on Westpac’s earnings and, in turn, its share price.

Diversification is key

One of the best ways to balance the risks and rewards of investing — in general — is to build a diverse portfolio.

Thus, I think anyone looking to buy Westpac shares would be wise to also consider investing in other stocks to better protect against single-sector or company downturns.

The post Investing $10k in Westpac shares could generate substantial passive income appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Could buying Westpac shares at under $22 make me rich?
• 3 Warren Buffett tips on how to invest in ASX 200 banks
• Buy these ASX 200 shares for massive dividends: analysts
• Why was the Westpac share price sold off in March?
• Does the Westpac share price fall make it a no-brainer buy?

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has recommended Westpac Banking. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/gZ5lBi3

The ANZ Group Holdings Ltd (ASX: ANZ) share price is pushing higher on Tuesday.

At the time of writing, the banking giant’s shares are up 1% to $23.50.

What’s going on with the ANZ share price?

Investors have been bidding the ANZ share price higher after the Australian Competition and Consumer Commission (ACCC) released its statement of preliminary views on the company’s proposed acquisition of the banking operations of Suncorp Group Ltd (ASX: SUN).

According to the release, the competition regulator is seeking further submissions to help it with its decision about whether to approve the proposed takeover.

For now, the ACCC has revealed that it believes there has been insufficient information to prove the public benefits from the deal. Its preliminary view is as follows:

The ACCC’s preliminary view is that the information currently before it is insufficient to substantiate the nature, likelihood and extent of the claimed public benefits, including ANZ’s estimates of future synergies that will be achieved and claims regarding public commitments to investment in Queensland or improvements in prudential stability arising from the Proposed Acquisition.

As for competition, the regulator highlights the potential overlap in agribusiness and small business lending. It adds:

The ACCC’s preliminary view is that the areas of competition between ANZ and Suncorp Bank that have the most potential to raise competition concerns stem from the activities in which they overlap, including: the supply of agribusiness banking, small and medium-sized enterprise (SME) banking, home loans and retail deposits (including transactions and savings accounts and term deposits). The ACCC also considers there is a higher degree of geographic overlap between ANZ and Suncorp Bank in Queensland and northern New South Wales.

The ACCC will now seek feedback from stakeholders, with submissions accepted up until 18 April. After which, a final decision on the takeover will be made on 12 June. The ACCC concludes:

The ACCC can only grant authorisation if it is satisfied in all the circumstances that either there is not a likely substantial lessening of competition, or that there are likely to be public benefits that outweigh any public detriments.

The post ANZ share price higher amid Suncorp Bank takeover news appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Brokers say these ASX dividend shares are buys
• 3 Warren Buffett tips on how to invest in ASX 200 banks
• Why did the ANZ share price crash 7% in March?
• ASX shares are paying out $19 billion in dividends this week. Are you getting a piece?
• Guess which ASX 200 bank stock UBS says is the most over-priced right now

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/3UfR94z